Gilead Sciences Names Andrew Dickinson Chief Financial Officer
October 15 2019 - 9:11AM
Dow Jones News
By Colin Kellaher
Gilead Sciences Inc. (GILD) Tuesday said it named Andrew
Dickinson chief financial officer, effective Nov. 1.
The Foster City, Calif., biopharmaceutical company said Mr.
Dickinson succeeds Robin Washington, who earlier this year
announced plans to retire.
Mr. Dickinson, who joined Gilead in 2016, currently serves as
executive vice president of corporate development and strategy and
will retain responsibility for those functions, the company
said.
Gilead in April said Ms. Washington would remain in an advisory
capacity through the completion of the company's reporting of its
2019 financial results early next year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 15, 2019 08:56 ET (12:56 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024